Tissue analysis demonstrated a higher proliferative index (Ki67-positive melanoma cells) and a pre-existing immune response with CD8-positive T cells in baseline melanoma biopsy samples of patients who had a pCR. This evidence concerns the gene CD8A and melanoma.